Literature DB >> 14770293

Novel estrogen receptor coregulators and signaling molecules in human diseases.

C J Barnes1, R K Vadlamudi, R Kumar.   

Abstract

The steroid hormone estrogen and signaling from its receptors are increasingly recognized as critical mediators of a variety of organ-specific biological processes. Recent advances in the identification and functional characterization of novel estrogen receptor interacting proteins clearly show the complexity of hormonal signaling regulation, but may also contribute to our understanding of the roles of estrogen signaling in normal physiology and the pathobiology of human disease.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14770293     DOI: 10.1007/s00018-003-3222-5

Source DB:  PubMed          Journal:  Cell Mol Life Sci        ISSN: 1420-682X            Impact factor:   9.261


  10 in total

1.  Image of the month. Behind the curtain of pericardial tamponade: cardiac hemangioendotheliosarcoma.

Authors:  Bernhard Maisch; Heinrich Bechtold; Roland Moll; Rainer Moosdorf
Journal:  Herz       Date:  2009-03       Impact factor: 1.443

Review 2.  [Left ventricular assist devices in chronic therapy of heart failure. Indication, results, risks].

Authors:  Anna L Meyer; Martin Strüber
Journal:  Herz       Date:  2009-03       Impact factor: 1.443

Review 3.  [Percutaneous aortic valve replacement - pro].

Authors:  Lutz Buellesfeld; Eberhard Grube
Journal:  Herz       Date:  2009-03       Impact factor: 1.443

4.  [Familial predisposition and microbial etiology in dilated cardiomyopathy].

Authors:  Sabine Pankuweit; Anette Richter; Volker Ruppert; Bernhard Maisch
Journal:  Herz       Date:  2009-03       Impact factor: 1.443

Review 5.  Genes causing inherited forms of cardiomyopathies. A current compendium.

Authors:  Matthias Paul; Sven Zumhagen; Birgit Stallmeyer; Matthias Koopmann; Tilmann Spieker; Eric Schulze-Bahr
Journal:  Herz       Date:  2009-03       Impact factor: 1.443

Review 6.  [Surgery or medical therapy for secondary mitral regurgitation?].

Authors:  Arnd Schaefer
Journal:  Herz       Date:  2009-03       Impact factor: 1.443

Review 7.  Prognostic factors in chronic heart failure. A review of serum biomarkers, metabolic changes, symptoms, and scoring systems.

Authors:  Mitja Lainscak; Stefan D Anker
Journal:  Herz       Date:  2009-03       Impact factor: 1.443

Review 8.  Heart failure with normal ejection fraction. Pathophysiology, diagnosis, and treatment.

Authors:  Carsten Tschöpe; Dirk Westermann
Journal:  Herz       Date:  2009-03       Impact factor: 1.443

Review 9.  [Percutaneous aortic valve implantation - contra].

Authors:  Klaus Kallenbach; Matthias Karck
Journal:  Herz       Date:  2009-03       Impact factor: 1.443

10.  Irbesartan in patients with heart failure and preserved ejection fraction.

Authors:  Barry M Massie; Peter E Carson; John J McMurray; Michel Komajda; Robert McKelvie; Michael R Zile; Susan Anderson; Mark Donovan; Erik Iverson; Christoph Staiger; Agata Ptaszynska
Journal:  N Engl J Med       Date:  2008-11-11       Impact factor: 91.245

  10 in total
  17 in total

Review 1.  Estrogen signaling crosstalk: Implications for endocrine resistance in ovarian cancer.

Authors:  Jennifer R Ribeiro; Richard N Freiman
Journal:  J Steroid Biochem Mol Biol       Date:  2014-02-22       Impact factor: 4.292

Review 2.  Focus on the glycerophosphocholine pathway in choline phospholipid metabolism of cancer.

Authors:  Kanchan Sonkar; Vinay Ayyappan; Caitlin M Tressler; Oluwatobi Adelaja; Ruoqing Cai; Menglin Cheng; Kristine Glunde
Journal:  NMR Biomed       Date:  2019-06-11       Impact factor: 4.044

3.  Functional implications of altered subcellular localization of PELP1 in breast cancer cells.

Authors:  Ratna K Vadlamudi; Bramanandam Manavathi; Seetharaman Balasenthil; Sujit S Nair; Zhibo Yang; Aysegul A Sahin; Rakesh Kumar
Journal:  Cancer Res       Date:  2005-09-01       Impact factor: 12.701

4.  Regulation of hormonal therapy resistance by cell cycle machinery.

Authors:  Binoj Chandrasekharan Nair; Ratna K Vadlamudi
Journal:  Gene Ther Mol Biol       Date:  2008-01-01

5.  Deregulation of estrogen receptor coactivator proline-, glutamic acid-, and leucine-rich protein-1/modulator of nongenomic activity of estrogen receptor in human endometrial tumors.

Authors:  Ratna K Vadlamudi; Seetharaman Balasenthil; Russell R Broaddus; Jan-Ake Gustafsson; Rakesh Kumar
Journal:  J Clin Endocrinol Metab       Date:  2004-12       Impact factor: 5.958

Review 6.  PELP1: A novel therapeutic target for hormonal cancers.

Authors:  Dimple Chakravarty; Rajeshwar Rao Tekmal; Ratna K Vadlamudi
Journal:  IUBMB Life       Date:  2010-03       Impact factor: 3.885

7.  Modulation of in situ estrogen synthesis by proline-, glutamic acid-, and leucine-rich protein-1: potential estrogen receptor autocrine signaling loop in breast cancer cells.

Authors:  Rajib Rajhans; Hareesh B Nair; Sujit S Nair; Valerie Cortez; Kijima Ikuko; Nameer B Kirma; Dujin Zhou; Alan E Holden; Darrell W Brann; Shiuan Chen; Rajeshwar Rao Tekmal; Ratna K Vadlamudi
Journal:  Mol Endocrinol       Date:  2007-12-13

Review 8.  Histone methylation modifiers in cellular signaling pathways.

Authors:  Hunain Alam; Bingnan Gu; Min Gyu Lee
Journal:  Cell Mol Life Sci       Date:  2015-08-25       Impact factor: 9.261

9.  Growth factor regulation of estrogen receptor coregulator PELP1 functions via Protein Kinase A pathway.

Authors:  Jatin K Nagpal; Sujit Nair; Dimple Chakravarty; Rajib Rajhans; Saikumar Pothana; Darrell W Brann; Rajeshwar Rao Tekmal; Ratna K Vadlamudi
Journal:  Mol Cancer Res       Date:  2008-05       Impact factor: 5.852

10.  Regulation of ER alpha signaling pathway in neuronal HN10 cells: role of protein acetylation and Hsp90.

Authors:  Tiina Suuronen; Johanna Ojala; Juha M T Hyttinen; Kai Kaarniranta; Anders Thornell; Sergiy Kyrylenko; Antero Salminen
Journal:  Neurochem Res       Date:  2008-02-29       Impact factor: 3.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.